C. Thioudellet, et al. CICON 2025 – Télécharger le Poster
Catégorie : -other-fr
Utilisation de l’analyseur xCELLigence RTCA eSight pour l’évaluation de la nouvelle platefrome de virus oncolytique de Transgene
B. Moreau et al.AFH 2025Télécharger le poster iciPoster présentation
Randomized phase II trial evaluating the combination of TG4001, a HPV16 therapeutic vaccineand avelumab (ave) in patients (pts) with immunotherapy-naïve recurrent and/or metastatic(R/M) HPV16-positive cervical or anogenital cancer
C. Le Tourneau, et al. ASCO 2025 Abstract disponible sur le site de l’ASCO – Télécharger abstract – Télécharger le Poster
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer
E. J. West et al.Clinical Cancer Research April 2025Lire l’article iciPublication
TG7010: a Novel Chimeric Oncolytic Poxvirus Encoding IL-12 with Improved Properties for Systemic Delivery
J. Foloppe, et al. IOVC 2024 Abstract disponible sur le site de l’IOVC – Télécharger l’ abstract et le poster
Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity
U. Hirigoyen, et al. Oncology 2024 Article disponible sur le site Molecular Therapy Oncology – Télécharger l’Article
Phase Ib/II trial of tipapkinogene sovacivec (TG4001), a therapeutic human papillomavirus 16-vaccine, in combination with avelumab in patients with advanced human papillomavirus 16-positive cancers
C. Le Tourneau, et al.European Journal of Cancer, July 2023 (191)Télécharger l’ ArticlePublication
Immunogenicity and clinical activity of Tipapkinogen sovacivec (TG4001), an HPV-16 cancer vaccine: a randomized phase 2 study in recurrent or metastatic (R/M) anogenital cancers
C. Le Tourneau, et al. ESMO 2023 Abstract disponible sur le site de l’ESMO – Télécharger l’abstract – Télécharger le poster
Advanced patient-derived lung tumoroids to identify limiting factors for oncolytic virotherapy
H. Le et al.AACR 2023Download the poster herePoster Presentation
PoxSTG, a novel chimeric poxvirus with improved oncolytic potency
P. Erbs et al.AACR 2023Download the poster herePoster Presentation